On 1/10/2020, by its unanimous Decision No. 718/2020, the Chamber of the Hellenic Competition Commission approved, pursuant to Art. 8(3) of Greek Law 3959/2011, the proposed transaction notified to it on 27/7/2020, which concerns the acquisition of of joint control by the companies (a) FARALLON CAPITAL MANAGEMENT LLC, through the company “HEALTHCARE INVESTORS II (GREECE) LLC” and (b) PIRAEUS BANK SA, over parts of the assets and liabilities of the company EUROMEDICA SA.

Pursuant to the above decision, the Hellenic Competition Commission found that the proposed concentration, which concerns the markets of private general clinics;  private obstetric clinics; private diagnostic centres; private recovery and rehabilitation centres; and private neuropsychiatric clinics, while falling within the scope of Art. 6(1) of Greek Law 3959/2011, does not raise any serious doubts as to its compatibility with the competition rules in the relevant market involved.